Revelstoke is a private equity firm formed by experienced investors who focus on building exceptional industry-leading companies.
Revelstoke has an investment track record of 30 acquisitions, which includes 8 platform investments and 22 add-on acquisitions, representing more than $1.4 billion of total enterprise value.
Revelstoke strives to partner with management teams to execute on a disciplined organic and acquisition strategy to build industry-leading companies and generate superior investment returns for management owners and investor partners.
- Per transaction equity commitment of $10 to $250 million
- EBITDA of at least $5 million
- Three year operating / profitable financial history
- Management / shareholders seeking a value added, strategy-oriented partner
- Strong growth prospects
- Opportunity to pursue acquisitions and consolidate within the industry
- Control investments including as sole investor or within a consortium
- Minority / growth equity investments
Healthcare and business services, including:
- Healthcare providers
- Healthcare education and training
- Revenue cycle services
- Medical technology
- Healthcare consumables and disposables
- Pharma services
- Outsourced healthcare services
- Transportation and logistics
- Specialty distribution
- Business and outsourced services
- Insurance and insurance services